These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32079866)
21. Granular cell variant of atypical fibroxanthoma. A case report. Němejcová K; Dundr P Cesk Patol; 2014 Jan; 50(1):34-7. PubMed ID: 24624985 [TBL] [Abstract][Full Text] [Related]
22. Clear cell variant of atypical fibroxanthoma and pleomorphic dermal sarcoma: Molecular characterization and review of the literature. Coelho-Lima J; Bruty J; Watkins J; Liu H; Price R; Stefanos N J Cutan Pathol; 2022 Dec; 49(12):1031-1034. PubMed ID: 35922373 [TBL] [Abstract][Full Text] [Related]
23. Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy. Klein S; Quaas A; Noh KW; Cartolano M; Abedpour N; Mauch C; Quantius J; Reinhardt HC; Buettner R; Peifer M; Helbig D Clin Cancer Res; 2020 Nov; 26(21):5638-5645. PubMed ID: 32817080 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. de Feraudy S; Mar N; McCalmont TH Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147 [TBL] [Abstract][Full Text] [Related]
25. Atypical fibroxanthoma: a selective review. Gru AA; Santa Cruz DJ Semin Diagn Pathol; 2013 Feb; 30(1):4-12. PubMed ID: 23327726 [TBL] [Abstract][Full Text] [Related]
31. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660 [TBL] [Abstract][Full Text] [Related]
32. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Soleymani T; Tyler Hollmig S Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020 [TBL] [Abstract][Full Text] [Related]
33. Novel p53 tumour suppressor mutations in cases of spindle cell sarcoma, pleomorphic sarcoma and fibrosarcoma in cats. Mayr B; Reifinger M; Alton K; Schaffner G Vet Res Commun; 1998 Jun; 22(4):249-55. PubMed ID: 9686439 [TBL] [Abstract][Full Text] [Related]
34. INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics. Orrock JM; Abbott JJ; Gibson LE; Folpe AL Am J Dermatopathol; 2009 Apr; 31(2):152-6. PubMed ID: 19318800 [TBL] [Abstract][Full Text] [Related]
35. Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene. Sabater-Marco V; Ferrando-Roca F; Morera-Faet A; García-García JA; Bosch SB; López-Guerrero JA Am J Dermatopathol; 2018 Mar; 40(3):225-227. PubMed ID: 28475508 [No Abstract] [Full Text] [Related]
36. Atypical fibroxanthoma in the setting of chronic lymphocytic leukemia and other non-Hodgkin lymphomas. Colgan MB; Brewer JD; Weaver AL; Roenigk RK; Otley CC Dermatol Surg; 2011 May; 37(5):671-6. PubMed ID: 21446993 [TBL] [Abstract][Full Text] [Related]
37. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets. Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378 [TBL] [Abstract][Full Text] [Related]
38. PDGFRa amplification in multiple skin lesions of undifferentiated pleomorphic sarcoma: A clue for intimal sarcoma metastases. Osio A; Vignon-Pennamen MD; Pedeutour F; Le Maignan C; Koskas F; Lebbé C; Janin A; Battistella M J Cutan Pathol; 2017 May; 44(5):477-479. PubMed ID: 28105789 [TBL] [Abstract][Full Text] [Related]